SDR16C5: A Drug Target / Disease Biomarker (G195814)

Target Name: SDR16C5

NCBI ID: G195814

SDR16C5

SDR16C5: A Drug Target / Disease Biomarker

SDR16C5 is a protein that is expressed in various tissues throughout the body. It is a key regulator of cell adhesion and has been implicated in a number of diseases, including cancer. As a drug target, SDR16C5 is a focus of research in the medical field, with various studies underway to investigate its potential as a therapeutic intervention.

SDR16C5 is a member of the SDR family, which includes several related proteins that are involved in the regulation of gene expression and cell adhesion. The SDR family proteins are known for their ability to sense and respond to various physical and chemical cues, such as changes in temperature, pH, and the presence of certain molecules in the environment.

SDR16C5 is involved in the regulation of cell adhesion and in the development of various diseases. One of the main functions of SDR16C5 is to regulate the formation of tight junctions, which are specialized barriers that separate cells and allow for the exchange of nutrients and other substances. In diseases such as cancer, SDR16C5 has been shown to play a role in the development and progression of these diseases.

SDR16C5 has also been shown to be involved in the regulation of cell signaling pathways that are involved in the development of various diseases, including cancer. For example, studies have shown that SDR16C5 can play a role in the regulation of the PI3K/Akt signaling pathway, which is involved in the regulation of cell growth, survival, and angiogenesis.

In addition to its role in cell signaling pathways, SDR16C5 has also been shown to be involved in the regulation of cellular processes that are important for the development of diseases. For example, studies have shown that SDR16C5 can play a role in the regulation of cell cycle progression, which is the process by which cells grow, divide, and replicate themselves.

SDR16C5 has also been shown to be involved in the regulation of cellular responses to various environmental cues, such as changes in temperature and pH. In diseases such as cancer, SDR16C5 has been shown to play a role in the regulation of cellular responses to these cues, which can contribute to the development and progression of these diseases.

As a drug target, SDR16C5 is a promising target for the development of therapeutic interventions for a number of diseases. Studies are underway to investigate the potential benefits and risks of targeting SDR16C5 as a drug, with potential therapeutic interventions being explored.

In conclusion, SDR16C5 is a protein that is involved in the regulation of cell adhesion and has been implicated in a number of diseases. As a drug target, SDR16C5 is a focus of research in the medical field, with various studies underway to investigate its potential as a therapeutic intervention. Further research is needed to fully understand the role of SDR16C5 in the development and progression of disease and to explore its potential as a therapeutic intervention.

Protein Name: Short Chain Dehydrogenase/reductase Family 16C Member 5

Functions: Oxidoreductase with strong preference for NAD (PubMed:18926804). Active in both the oxidative and reductive directions (PubMed:18926804). Oxidizes all-trans-retinol in all-trans-retinaldehyde (PubMed:18926804). No activity was detected with 11-cis-retinol or 11-cis-retinaldehyde as substrates with either NAD(+)/NADH or NADP(+)/NADPH (PubMed:18926804)

The "SDR16C5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SDR16C5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets